All Phenotypes Thra<tm1Syc> MGI Mouse

postnatal growth retardation ( J:103351 )

abnormal long bone diaphysis morphology ( J:217018 )

• bones exhibit abnormal cross-section throughout the diaphysis

abnormal long bone epiphyseal plate morphology ( J:103351 )

• at 7 weeks of age, the growth plate is wider than in controls, similar to the width seen at 4 weeks of age in wild-type

abnormal long bone epiphyseal ossification zone morphology ( J:103351 )

• reduced ossification of the secondary tibial epiphyses

abnormal long bone epiphyseal plate proliferative zone ( J:103351 )

• the PZ region is 5% narrower than in controls

decreased width of hypertrophic chondrocyte zone ( J:103351 )

• the HZ region is 10% narrower than in controls

increased long bone epiphyseal plate size ( J:217018 )

• growth plates in 14 and 20 week old mice are 39% and 70% wider, respectively, than in wild-type mice, indicating persistent delay of endochondral ossification

abnormal long bone metaphysis morphology ( J:217018 )

• bones exhibit splayed metaphyses

decreased length of long bones ( J:217018 )

• bones from 14 and 20 week old mice are 17% and 15% shorter, respectively

short ulna ( J:103351 )

• ulnas are 12-14% shorter

short tibia ( J:103351 )

• tibias are 15-25% shorter than tibias at all postnatal ages examined, however no differences at E17.5 or P1 are seen

increased diameter of long bones ( J:217018 )

• periosteal diameter is 13% and 20% larger at 14 and 20 weeks of age, respectively

• T4 treatment does not change endosteal diameter compared to a 16% increase in wild-type mice

abnormal bone structure ( J:103351 )

decreased osteoclast cell number ( J:217018 )

• osteoclast surfaces are reduced and fewer osteoclasts are present, with mice having a smaller proportion of their increased bone surface covered by osteoclasts

• T4 treatment accentuates the osteoclast phenotype

abnormal bone mineral content ( J:217018 )

• mice have an increase in bone mineral content despite a reduction in tissue mineralization density

decreased bone mineral content ( J:217018 )

• lower bone mineral content at 14 weeks of age

increased bone mineral content ( J:217018 )

• higher bone mineral content at 20 weeks of age

• supraphysiological T4 treatment further increases bone mineral content in mutants unlike in wild-type mice which show reduced bone mineral content after treatment, indicating that mice are resistant to T4-induced bone loss

abnormal compact bone morphology ( J:103351 )

• cortical bone deposition in the tibial diaphysis is reduced by about 50% in 2 week old heterozygotes

increased compact bone volume ( J:217018 )

increased compact bone thickness ( J:217018 )

• cortical bone thickness is 48% and 43% wider at 14 and 20 weeks of age, respectively

• T4 treatment has no effect on these bone abnormalities but results in a gradual increase in cortical bone thickness and diameter

abnormal trabecular bone morphology ( J:103351 )

• reduction in deposition of calcified trabecular bone at 2 weeks of age

increased trabecular bone volume ( J:217018 )

• trabecular bone volume is increased 2.1-fold in 20 week old mice

increased bone trabecula number ( J:217018 )

• trabecula number is increased 1.9-fold in 20 week old mice

increased trabecular bone thickness ( J:217018 )

• trabecular bone thickness is increased 1.1-fold in 20 week old mice

abnormal joint morphology ( J:217018 )

• bones exhibit misshapen joint surfaces

large fontanelles ( J:103351 )

• fontanelles are larger in neonates

wide cranial sutures ( J:103351 )

• cranial sutures are wider than in wild-type at E17.5 and in neonates

abnormal bone mineralization ( J:103351 , J:217018 )

	• reduction in trabecular bone mineralization (J:103351)
	• cortical and trabecular bone mineralization density is reduced in 20 week old mice, with greater reduction in cortical bone; T4 treatment does not affect mineralization (J:217018) • mice have an increase in bone mineral content but bone is less mineralized (J:217018)

delayed endochondral bone ossification ( J:103351 , J:217018 )

• small delay in endochondrial ossification in the ulna and radius of the forelimb and in the tibia and fibula of the hindlimb at E17.5 and in neonates (J:103351)

• endochondrial ossification is delayed by 3 to 4 weeks in adult mutants, resulting in smaller tibias in all directions, delayed development of the second ossification center, of the growth plate and subsequent growth plate narrowing (J:103351)

• hindlimb paws at 3 and 7 weeks of age show impaired endochondral bone formation with delayed formation of secondary ossification centers in metatarsal bones at 2 weeks and the presence of open metatarsal growth plates at 7 weeks (J:103351)

• growth plates in 14 and 20 week old mice are 39% and 70% wider, respectively, than in wild-type mice, indicating persistent delay of endochondral ossification (J:217018)

• T4 treatment does not have an effect on the delayed endochondral ossification (J:217018)

delayed intramembranous bone ossification ( J:103351 )

• intramembranous bone deposited in frontal and parietal bones is more porous and stains less intensely, indicating delayed intramembranous ossification of the skull

delayed cranial suture closure ( J:103351 )

abnormal bone remodeling ( J:217018 )

• increase in retention of mineralized cartilage within trabeculae in 14 and 20 week old mice, indicating impaired bone modeling

• T4 treatment does not have an effect on the impaired bone remodeling

abnormal osteoclast physiology ( J:217018 )

• reduction in osteoclastic bone resorption

decreased bone resorption ( J:217018 )

• reduction in osteoclastic bone resorption, however bone formation parameters are similar to wild-type mice

abnormal bone strength ( J:217018 )

• mice show normal bone strength, however prolonged T4 treatment results in increased bone stiffness and strength

decreased osteoclast cell number ( J:217018 )

• osteoclast surfaces are reduced and fewer osteoclasts are present, with mice having a smaller proportion of their increased bone surface covered by osteoclasts

• T4 treatment accentuates the osteoclast phenotype

abnormal osteoclast physiology ( J:217018 )

• reduction in osteoclastic bone resorption

abnormal hormone level ( J:217018 )

• reduction in T4:T3 ratio

• supraphysiological T4 treatment attenuates the increases in circulating T4 and T3 concentrations that are seen in wild-type mice, indicating resistance to T4 administration

increased triiodothyronine level ( J:217018 )

• basal T3 levels are increased by 1.5-fold

• however, basal T4 levels do not differ from wild-type mice

increased thyroid-stimulating hormone level ( J:217018 )

• basal TSH levels are increased by 6-fold

• supraphysiological T4 treament from weaning at 4 weeks of age until analysis at 20 weeks of age completely suppresses TSH is both wild-type and heterozygotes

decreased osteoclast cell number ( J:217018 )

• osteoclast surfaces are reduced and fewer osteoclasts are present, with mice having a smaller proportion of their increased bone surface covered by osteoclasts

• T4 treatment accentuates the osteoclast phenotype

abnormal osteoclast physiology ( J:217018 )

• reduction in osteoclastic bone resorption

short ulna ( J:103351 )

• ulnas are 12-14% shorter

short tibia ( J:103351 )

• tibias are 15-25% shorter than tibias at all postnatal ages examined, however no differences at E17.5 or P1 are seen

large fontanelles ( J:103351 )

• fontanelles are larger in neonates

wide cranial sutures ( J:103351 )

• cranial sutures are wider than in wild-type at E17.5 and in neonates

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 12/10/2024 MGI 6.24